Búsqueda de Publicación - Prisma - Unidad de Bibliometría

Publicaciones en la fuente BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Tipo Año Título Fuente
Artículo2020Polyphenolic extract (PE) from olive oil exerts a potent immunomodulatory effect and prevents graft-versus-host disease in a mouse modelBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2020Potential Survival Benefit for Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation after Nivolumab Therapy for Relapse/Refractory Hodgkin Lymphoma: Real-Life Experience in SpainBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2019Allocation to Matched Related or Unrelated Donor Results in Similar Clinical Outcomes without Increased Risk of Failure to Proceed to Transplant among Patients with Acute Myeloid Leukemia: A Retrospective Analysis from the Time of Transplant ApprovalBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2019Response to Novel Drugs before and after Allogeneic Stem Cell Transplantation in Patients with Relapsed Multiple MyelomaBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2019Thrombopoietin receptor agonists for severe thrombocytopenia after allogeneic stem cell transplantation: experience of the Spanish group of hematopoietic stem cell transplantBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2018CD34+ Cell Selection versus Reduced-Intensity Conditioning and Unmodified Grafts for Allogeneic Hematopoietic Cell Transplantation in Patients Age >50 Years with Acute Myelogenous Leukemia and Myelodysplastic SyndromeBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2017Donor CTLA-4 Genotype Modulates the Immune Response to Minor Histocompatibility Antigen MismatchesBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2016Fludarabine/Busulfan versus Fludarabine/Melphalan Conditioning in Patients Undergoing Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation for LymphomaBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2016Outcome of Second Allogeneic Hematopoietic Cell Transplantation after Relapse of Myeloid Malignancies following Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort on Behalf of the Grupo Espanol de Trasplante HematopoyeticoBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2015Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant ResearchBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2014Combination of the Hematopoietic Cell Transplantation Comorbidity Index and the European Group for Blood and Marrow Transplantation Score Allows a Better Stratification of High-Risk Patients Undergoing Reduced-Toxicity Allogeneic Hematopoietic Cell TransplantationBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2014Gene and miRNA Expression Profiles of Hematopoietic Progenitor Cells Vary Depending on Their OriginBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2014Mismatch on Glutathione S-Transferase T1 Increases the Risk of Graft-versus-Host Disease and Mortality after Allogeneic Stem Cell TransplantationBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2014Sequential Third-Party Mesenchymal Stromal Cell Therapy for Refractory Acute Graft-versus-Host DiseaseBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2013Impact of Hyperferritinemia on the Outcome of Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Lymphoid MalignanciesBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2011Helicobacter pylori Infection and Graft-versus-Host DiseaseBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2011Limbus Damage in Ocular Graft-versus-Host DiseaseBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2011Pretransplantation Liver Function Impacts on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation: A Study of 455 PatientsBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2010Unrelated Transplantation for Poor-Prognosis Adult Acute Lymphoblastic Leukemia: Long-Term Outcome Analysis and Study of the Impact of Hematopoietic Graft SourceBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2009Alemtuzumab as Treatment of Steroid-Refractory Acute Graft-versus-Host Disease: Results of a Phase II StudyBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2009Oral Beclomethasone Dipropionate for the Treatment of Gastrointestinal Chronic Graft-versus-Host DiseaseBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2008Prognostic factors of chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation: The national institutes health scale plus the type of onset can predict survival rates and the duration of immunosuppressive therapyBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2008Reduced-intensity conditioning allogeneic transplantation from unrelated donors: Evaluation of mycophenolate mofetil plus cyclosporin a as graft-versus-host disease prophylaxisBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2007Sirolimus as part of immunosuppressive therapy for refractory chronic graft-versus-host diseaseBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2006Oral beclomethasone dipropionate for the treatment of gastrointestinal acute graft-versus-host disease (GVHD)BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2005Long-term immune recovery of patients undergoing allogeneic stem cell transplantation: A comparison with their respective sibling donorsBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2005Reduced-intensity conditioning stem cell transplantation with allogeneic blood fludarabine and oral busulfan with or without pharmacokinetically targeted busulfan dosing in patients with myeloid leukemia ineligible for conventional conditioningBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2004Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myelomaBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION